Govt releases FAQs on strategic restructuring of IDBI Bank Ltd (See 'Corp Brief') CCI approves acquisition of majority stake in Tribhovandas Bhimji Zaveri by GRT Jewellers (See 'Corp Brief') CCI okays acquisition of equity in Kids Clinic India by NuageLux BidCo S.à r.l (See 'Corp Brief') A&C - Licence Agreement governing patent licences, JVA creating Indian joint venture, and MoU governing liaison services, operate in distinct fields and are not subservient to Licence Agreement: SC LB (See 'Legal Desk') CCI approves acquisition of shares in FarMart Service by Impact Fund Denmark (See 'Corp Brief') Govt approves Strategic Restructuring of IDBI Bank (See 'Corp Brief') Joshi highlights Role of Standards in India's Clean Energy Transition (See 'Corp Brief') IBC - Moratorium u/s 14 of the IBC does not apply to a surety in a contract of guarantee to the Corporate Debtor: NCLT (See 'Legal Desk') NSDF, SAI join hands with Indian Oil to bolster Boxing ecosystem in India (See 'Corp Brief') Centre unveils measures giving filip to shipbuilding industry (See 'Corp Brief') NIFTEM-K Hosts India-Canada Roundtable on Pulse Protein Innovation, Value Addition and Strategic Partnerships (See 'Corp Brief') FEMA - Expression 'in charge' contemplates control over day to day business of company & liability cannot be imposed merely on basis of designation in absence of material establishing such responsibility: SAFEMA Tribunal (See 'Legal Desk') HM hosts first meeting of BIMSTEC Home Ministers in New Delhi (See 'Corp Brief') Taking Voice-First Multilingual AI Beyond Borders: BHASHINI at NCGG Mussoorie (See 'Corp Brief') From Farms to Borders: NH-22 Four-Laning Project to boost eonnectivity in Bihar (See 'Corp Brief') Prevention of Corruption Act - Where a company is not an accused, authority cannot attach properties of a person on grounds that said person managed affairs of said company, without showing that proceeds of crime reached said company & were used for acquiring the attached property: SAFEMA Tribunal (See 'Legal Desk') India-UK partnership focuses on industry-led research (See 'Corp Brief') Centre urges States to ensure Display of Healthcare Service Rates at Clinical Establishments (See 'Corp Brief') Chouhan calls for Coordinated Action to boost Farm Incomes (See 'Corp Brief') Companies Act - Subsisting judgment of a Court is required to be complied with by concerned Ministry/authorities & intention to file review petition per se does not constitute grounds for withholding compliance with existing judgment: HC (See 'Legal Desk') Union Minister calls for outcome-oriented implementation of PMDDKY (See 'Corp Brief') BRICS Theatre Festival 2026 commences at National School of Drama (See 'Corp Brief') Reddy launches commercialisation catalogue of technologies (See 'Corp Brief') PMLA - Allegations of contravention of the UAPA, by itself, cannot justify indefinite pre-trial detention in separate PMLA proceedings carrying maximum sentence of seven years: HC (See 'Legal Desk') MeitY Pavilion showcases India's digital innovation at India Mobile Congress 2026 (See 'Corp Brief') DRI seizes around 5.8 kg foreign-origin gold worth Rs. 9 crores (See 'Corp Brief') Keylong to house ICMR's first dedicated centre for high-altitude medicine (See 'Corp Brief') SARFAESI - Demand notice issued under Rule 7(1) of IBC Rules, 2019 does not, per se, commence insolvency proceedings against personal guarantors or trigger interim moratorium per Section 96 of IBC 2016: HC (See 'Legal Desk') Digital Health Resources crucial to Building India's Research Mindset: Health Secy (See 'Corp Brief') 53 Tele-MANAS Cells operational across all 36 States (See 'Corp Brief') CSR is not merely a statutory obligation but as strategic instrument for India's growth: Former Cab Secry (See 'Corp Brief') FEMA - Intimation to Customs does not, by itself, constitute proof of import of software, particularly where the software was claimed to have been received through a data communication channel: Tribunal (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT)

Print

Glenmark's Swiss arm gets nod to market Ryaltris nasal spray in Russia

Published: Feb 22, 2021

By TIOLCORPLAWS News Service

NEW DELHI, FEB 22, 2021: GLENMARK Pharmaceuticals on Monday said its Swiss subsidiary, Glenmark Specialty, has received marketing approval from Russian health regulators for its fixed-dose combination nasal spray, Ryaltris.

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, like stuffy and runny nose, nasal itching, sneezing, as well as irritated eyes, in adults and children over 12 years of age.

"Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally. Russia is one of the key markets for us and we are consistently looking to expand our product portfolio," said Csaba Kantor, Senior Vice President - Russia and CIS region, Glenmark.

In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent.

"Glenmark has a strong established presence in Russia for over 30 years, which will enable us to lead the commercialization of this product in the country. We look forward to being able to make this innovative product available to patients in Russia as soon as possible," Mr Kantor added.

The company estimated that Ryaltris will be available to patients in Russia by the first quarter of 2021-22.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.